DMT Study ‘Breaks the Hiatus’ in Psychedelic Drug Testing

Researchers test the psychological effects of intravenously-administered DMT in healthy volunteers and find they begin almost immediately, peak at 90-120 seconds, and are almost completely resolved by 30 minutes.

February 1994

In a dose-response study in humans, researchers find the psychological effects of intravenously-administered DMT (N,N-dimethyltryptamine) begin almost immediately, peak at 90-120 seconds, and are almost completely resolved by 30 minutes. The volunteers experienced hallucinogenic effects at doses of 0.2 and 0.4 mg/kg. 0.1 mg/kg produced the least desirable effects.

March 21, 2018 article in the Harvard Political Review says this study on DMT “broke the hiatus “in psychedelic drug testing that had been going on for about two decades and is the start of the “psychedelic renaissance.”